Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.7K Buy
692
+6
+0.9% +$548 0.05% 97
2026
Q1
$70.5K Buy
686
+3
+0.4% +$339 0.06% 89
2025
Q4
$85.5K Buy
+683
New +$87K 0.08% 85

Other funds holding ABT

CrossGen Wealth's ABT Position: Q2 2026 in Review

CrossGen Wealth increased its Abbott (ABT) stake by 0.87% in Q2 2026, buying an estimated $548 and bringing the position to 692 shares worth $62.7K. The position accounts for 0.05% of the portfolio, ranked #97.

CrossGen Wealth first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $85.5K in Q4 2025. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • CrossGen Wealth held 692 shares of Abbott worth $62.7K as of Q2 2026.
  • CrossGen Wealth bought 6 Abbott shares in Q2 2026, an estimated $548.
  • Abbott made up 0.05% of CrossGen Wealth's portfolio in Q2 2026, its #97 holding.
  • CrossGen Wealth first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
  • CrossGen Wealth's Abbott position peaked at $85.5K in Q4 2025.
  • 2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.